Nav: Home

Recent thyroid cancer trends in the United States suggest age, racial disparities

April 01, 2017

ORLANDO--In the United States, thyroid cancer incidence is rising among young people as well as Hispanics and African Americans, a new study reports. Results of this research will be presented in a poster Monday, April 3, at ENDO 2017, the annual scientific meeting of the Endocrine Society, in Orlando, Fla.

"Thyroid cancer incidence is leveling off in the United States. Our analysis, however, shows that the trend of deceleration mainly occurred in non-Hispanic Whites and in older populations, whereas the rate of thyroid cancer continuously increased among the young and the Hispanic and black populations," said lead author Anupam Kotwal, M.B.B.S., clinical fellow in the Division of Endocrinology, Diabetes, Metabolism and Nutrition at Mayo Clinic in Rochester, Minn.

"Our findings are important because they suggest disparity in thyroid cancer diagnosis with possible implications in disease-specific outcomes as well as societal and economic costs," he added.

To examine the trend of thyroid cancer in different age and gender subgroups, Kotwal and colleagues reviewed age-adjusted incidence, including average percent change in incidence and trends in age-adjusted rates from the National Cancer Institute Surveillance, Epidemiology, and End Results (SEER 18) program. They analyzed data from the years 2000 through 2013 using the publicly available online interactive tool (SEER*Explorer).

From 2000 to 2013, thyroid cancer incidence increased from 7.4 to 14.5 cases per 100,000 people, with an average change of 6.7 percent from 2000 through 2009 and 2.4 percent from 2010 through 2013.

In Hispanics and African Americans, thyroid cancer incidence has continuously increased, with an average change of 4.7 percent and 5.1 percent respectively, while for non-Hispanic Whites, the average change decelerated from 7.1 percent before 2009 to 2.2 percent after 2009.

Stratified by age group, thyroid cancer continued to accelerate at an unchanged rate only among people 20 years of age and below. Among those 75 years of age and above, though, the rising incidence stabilized after 2009, with an average change of 1 percent.

Females and males showed similar deceleration in their overall rates after 2009, with average changes of 2.3 percent and 2.8 percent, respectively.

When subgroups were combined based on their association with acceleration or deceleration rates, the group with the highest average percent change without any evidence of deceleration was Hispanic females between the ages of 20 and 49 years.

"These findings are consistent with recent reports demonstrating that thyroid cancer is the second most common cancer among Hispanic females, female adolescents and young adults. Drivers for these variations in thyroid cancer trends are unknown and require further investigation," Kotwal said.

"Future analysis will demonstrate if this change in thyroid cancer incidence persists. Whether this increase in incidence is due to more testing (e.g., thyroid ultrasound) or truly represents a higher predilection of these patient groups for thyroid cancer will need further investigation," he added.
Juan P. Brito, M.B.B.S., assistant professor of medicine at the Mayo Clinic in Rochester, Minn. was senior author of the study with Kotwal. The study received no external funding.

Endocrinologists are at the core of solving the most pressing health problems of our time, from diabetes and obesity to infertility, bone health, and hormone-related cancers. The Endocrine Society is the world's oldest and largest organization of scientists devoted to hormone research and physicians who care for people with hormone-related conditions.

The Society has more than 18,000 members, including scientists, physicians, educators, nurses and students in 122 countries. To learn more about the Society and the field of endocrinology, visit our site at Follow us on Twitter at @TheEndoSociety and @EndoMedia.

The Endocrine Society

Related Thyroid Cancer Articles:

For low-risk thyroid cancer patients, less may be more for post-surgery surveillance
Patient self-advocacy is important, and although a maximizing preference may be advantageous in many situations, new research led by the University of Michigan Rogel Cancer Center shows that, in the case of long-term surveillance of treated, low-risk thyroid cancer, health care ''maximizers'' consume more health care resources -- such as doctor visits and diagnostic imaging tests -- which drive up costs without a clear improvement in outcomes.
New test for thyroid cancer could prevent unnecessary surgery
Each year, thanks to inconclusive tests for thyroid cancer, thousands of people undergo unnecessary surgeries to remove part or all of their thyroids.
Raman spectroscopy poised to make thyroid cancer diagnosis less invasive
Researchers have demonstrated that an optical technique known as Raman spectroscopy can be used to differentiate between benign and cancerous thyroid cells.
Are doctors treating more thyroid cancer patients than necessary?
New research may help change treatment practices for patients diagnosed with low risk thyroid cancer.
Is thyroid hormone therapy for early underactive thyroid associated with better quality of life?
An early form of underactive thyroid (when the body doesn't produce enough thyroid hormones) called subclinical hypothyroidism is a common condition but the benefit of thyroid hormone therapy on quality of life and symptoms is uncertain.
More Thyroid Cancer News and Thyroid Cancer Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Erasing The Stigma
Many of us either cope with mental illness or know someone who does. But we still have a hard time talking about it. This hour, TED speakers explore ways to push past — and even erase — the stigma. Guests include musician and comedian Jordan Raskopoulos, neuroscientist and psychiatrist Thomas Insel, psychiatrist Dixon Chibanda, anxiety and depression researcher Olivia Remes, and entrepreneur Sangu Delle.
Now Playing: Science for the People

#537 Science Journalism, Hold the Hype
Everyone's seen a piece of science getting over-exaggerated in the media. Most people would be quick to blame journalists and big media for getting in wrong. In many cases, you'd be right. But there's other sources of hype in science journalism. and one of them can be found in the humble, and little-known press release. We're talking with Chris Chambers about doing science about science journalism, and where the hype creeps in. Related links: The association between exaggeration in health related science news and academic press releases: retrospective observational study Claims of causality in health news: a randomised trial This...